Back to Browse Journals » Orphan Drugs: Research and Reviews » Volume 2

Betaine treatment of cystathionine β-synthase-deficient homocystinuria; does it work and can it be improved?

Authors Maclean KN

Published Date September 2012 Volume 2012:2 Pages 23—33

DOI http://dx.doi.org/10.2147/ODRR.S27597

Received 6 July 2012, Accepted 14 August 2012, Published 28 September 2012

Kenneth N Maclean

Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA

Abstract: Inactivating mutations in cystathionine β-synthase result in classical homocystinuria (HCU) and are typically accompanied by severe elevations of plasma and tissue homocysteine, methionine, S-adenosylmethionine, S-adenosylhomocysteine and significantly decreased cysteine. HCU is usually accompanied by marfanoid skeletal abnormalities, osteoporosis, ectopia lentis and/or severe myopia, cognitive impairment, and a dramatically increased incidence of atherosclerosis and thromboembolic complications of variable presentation. If untreated, HCU is a serious life-threatening disease. Betaine (N,N,N-trimethylglycine) is a zwitterionic quaternary ammonium compound that can lower homocysteine, S-adenosylmethionine, S-adenosylhomocysteine, and increase cysteine in HCU by serving as a methyl donor for the remethylation of homocysteine in a reaction catalyzed by betaine–homocysteine S-methyltransferase. This review considers the clinical efficacy and safety of betaine treatment of HCU. Possible strategies by which the efficacy of this treatment might be improved are discussed.

Keywords: homocystinuria, homocysteine, betaine, cystathionine beta-synthase, betaine–homocysteine S-methyltransferase

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model

Vinh NQ, Naka S, Cabral H, Murayama H, Kaida S, Kataoka K, Morikawa S, Tani T

International Journal of Nanomedicine 2015, 10:4137-4147

Published Date: 25 June 2015

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy

Tseng SH, Chou MY, Chu IM

International Journal of Nanomedicine 2015, 10:3663-3685

Published Date: 20 May 2015

Integration of nondegradable polystyrene and degradable gelatin in a core–sheath nanofibrous patch for pelvic reconstruction

Ge LP, Li QT, Jiang JZ, You XY, Liu ZH, Zhong W, Huang Y, Xing MMQ

International Journal of Nanomedicine 2015, 10:3193-3201

Published Date: 24 April 2015

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138–  CD34– tumor stem-like cells in multiple myeloma-bearing mice

Yang C, Wang J, Chen D, Chen J, Xiong F, Zhang H, Zhang Y, Gu N, Dou J

International Journal of Nanomedicine 2013, 8:1439-1449

Published Date: 12 April 2013

Development of a novel niosomal system for oral delivery of Ginkgo biloba extract

Jin Y, Wen JY, Garg S, Liu D, Zhou YL, Teng LR, Zhang WY

International Journal of Nanomedicine 2013, 8:421-430

Published Date: 24 January 2013

Long-term MRI tracking of dual-labeled adipose-derived stem cells homing into mouse carotid artery injury

Qin JB, Li KA, Li XX, Xie QS, Lin JY, Ye KC, Jiang ME, Zhang GX, Lu XW

International Journal of Nanomedicine 2012, 7:5191-5203

Published Date: 2 October 2012

Gold nanoparticles and diclofenac diethylammonium administered by iontophoresis reduce inflammatory cytokines expression in Achilles tendinitis

Dohnert MB, Venâncio M, Possato JC, Zeferino RC, Dohnert LH, Zugno AI, De Souza CT, Paula MMS, Luciano TF

International Journal of Nanomedicine 2012, 7:1651-1657

Published Date: 26 March 2012